text_1: Angiotensin converting enzyme inhibitors are associated with decreased risk for functional renal insufficiency.
text_2: Although ACE inhibitor therapy usually improves renal blood flow (RBF) and sodium excretion rates in CHF and reduces the rate of progressive renal injury in chronic renal disease, its use can also be associated with a syndrome of “functional renal insufficiency” and/or hyperkalemia.